| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |